Eli Lilly and Company
NYSE-LLY
Basic
Market Cap
$699.39B
EV
$722.47B
Shares Out
900.41M
Revenue
$35.93B
Employees
43,000
Margins
Gross
80.16%
EBITDA
37.22%
Operating
32.86%
Pre-Tax
21.04%
Net
17.08%
FCF
-0.25%
Returns (5Yr Avg)
ROA
13.52%
ROTA
-603.61%
ROE
94.37%
ROCE
24.48%
ROIC
20.12%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$845.32
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$2,652.5M
Net Debt
$22.99B
Debt/Equity
2.04
EBIT/Interest
20.98
Growth (CAGR)
Rev 3Yr
12.13%
Rev 5Yr
10.69%
Rev 10Yr
4.94%
Dil EPS 3Yr
0.55%
Dil EPS 5Yr
1.99%
Dil EPS 10Yr
6.62%
Rev Fwd 2Yr
22.58%
EBITDA Fwd 2Yr
55.96%
EPS Fwd 2Yr
69.33%
EPS LT Growth Est
35.41%
Dividends
Yield
—
Payout
68.77%
DPS
$4.69
DPS Growth 3Yr
15.17%
DPS Growth 5Yr
14.99%
DPS Growth 10Yr
9.12%
DPS Growth Fwd 2Yr
14.99%
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)